Evidence map›Paper›PMID 29023497›Full record

ArticlePloS one2017

Characterization of PAX9 variant P20L identified in a Japanese family with tooth agenesis.

Akiko Murakami, Shinji Yasuhira, Hisayo Mayama, Hiroyuki Miura, Chihaya Maesawa, Kazuro Satoh

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Epigenetic, Genetic, and Functional Germline Alterations ofCurrent issues in molecular biology · 2026
    Review
  2. Article
  3. A novel PAX9 variant in a Chinese family with non-syndromic oligodontia and genotype-phenotype analysis of PAX9variants.Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2024
    Article
  4. NovelJournal of personalized medicine · 2024
    Article
  5. Article
  6. The First Report of a Missense Variant inFrontiers in genetics · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Akiko MurakamiDepartment of Developmental Oral Health Science, School of Dentistry, Iwate Medical University, Uchimaru, Morioka, Iwate, Japan.
Shinji YasuhiraDepartment of Tumor Biology, Institute of Biomedical Sciences, Iwate Medical University, Nishitokuta, Yahaba-cho, Shiwa-gun, Iwate, Japan.ORCID http://orcid.org/0000-0003-0041-3545
Hisayo MayamaDepartment of Developmental Oral Health Science, School of Dentistry, Iwate Medical University, Uchimaru, Morioka, Iwate, Japan.
Hiroyuki MiuraDepartment of Oral Medicine, School of Dentistry, Iwate Medical University, Uchimaru, Morioka, Iwate, Japan.
Chihaya MaesawaDepartment of Tumor Biology, Institute of Biomedical Sciences, Iwate Medical University, Nishitokuta, Yahaba-cho, Shiwa-gun, Iwate, Japan.
Kazuro SatohDepartment of Developmental Oral Health Science, School of Dentistry, Iwate Medical University, Uchimaru, Morioka, Iwate, Japan.
Iwate Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcription factors PAX9 and MSX1 play crucial roles in the development of permanent teeth at the bud stage, and their loss-of-function variants have been associated with congenital tooth agenesis. We sequenced the coding regions of the PAX9 and MSX1 genes from nine patients with non-syndromic tooth agenesis, and identified a missense mutation, P20L, of PAX9 in a single familial case involving three patients in two generations. Identical mutation was previously reported by other authors, but has not been characterized in detail. The mutation was located in a highly conserved N-terminal subdomain of the paired domain and co-segregated as a heterozygote with tooth agenesis. The patients showed defects primarily in the first and second molars, which is typical for cases attributable to PAX9 mutation. Luciferase reporter assay using the 2.3-kb promoter region of BMP4 and electrophoretic mobility shift assay using the CD19-2(A-ins) sequence revealed that P20L substitution eliminated most of the transactivation activity and specific DNA binding activity of PAX9 under the experimental conditions we employed, while some residual activity of the mutant was evident in the former assay. The hypomorphic nature of the variant may explain the relatively mild phenotype in this case, as compared with other PAX9 pathogenic variants such as R26W.

Indexed as

AdolescentAdultAnimalsAnodontiaBone Morphogenetic Protein 4Chlorocebus aethiopsCOS CellsElectrophoretic Mobility Shift AssayFemaleHumansMaleMiddle AgedModels, MolecularMSX1 Transcription FactorPAX9 Transcription FactorPedigreeBMP4 protein, humanBone Morphogenetic Protein 4MSX1 protein, humanMSX1 Transcription FactorPAX9 protein, humanPAX9 Transcription Factor

Identifiers

PMID29023497
PMCPMC5638407
OpenAlexW2761335027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.